Second, Wnt signaling, where, in cultured tumor cells, TNC binds to the Wnt3a ligand, thus either promoting (when TNC and Wnt3a are offered as substratum) or inhibiting Frz signaling (when offered as soluble molecules) (Hendaoui et al., 2014). This evidence concerns the gene WNT3A and neoplasm.